About this trial
This observational study aims to explore the association between oral and salivary biomarkers and stroke. The study will include adult participants diagnosed with stroke and will analyze clinical, oral, and salivary parameters. The objective is to improve understanding of potential links between oral health, salivary biomarkers, and cerebrovascular disease. No experimental intervention will be performed.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adults aged 18 to 90 years.
Patients diagnosed with stroke (ischemic or hemorrhagic) confirmed by clinical and imaging criteria for the stroke group.
Healthy volunteers without a history of stroke or cerebrovascular disease for the control group.
Ability to provide written informed consent.
Disqualifiers
inflammatory disease at the time of sampling.
Chronic autoimmune or malignant disease.
Recent major surgery or trauma within the last 3 months.
Pregnancy or breastfeeding.
Trial population
Patients will be recruited from multiple regions within Algeria, reflecting a diverse national population.
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Differences in salivary inflammatory biomarker profiles between stroke patients and healthy controls.
Assessment of salivary inflammatory and neuroendocrine biomarkers, including salivary cortisol and selected inflammatory cytokines (e.g., IL-6 and/or hs-CRP), to identify biomarker patterns associated with stroke.
Secondary outcomes
Exploratory association between oral microbiota profiles and stroke status
Exploratory analysis of the association between oral microbiota profiles and stroke status using saliva or oral swab samples. The analysis aims to identify bacterial profiles potentially associated with stroke and oral-systemic interactions.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: